State Street SPDR S&P Biotech ETF (XBI) Stock Price Today
Aura AI Summary
Key Stats
- $10.50BMarket Cap
- 8,846,777Volume
- Broad Market / FactorSector
- $169.5552W High
- $93.7752W Low
- 33 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 28% Sell | 72% BuyTrading Activity
Track State Street SPDR S&P Biotech ETF (XBI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $93.77 and a high of $169.55, highlighting its annual price range. Buy and sell State Street SPDR S&P Biotech ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Most Recent News
EMCOR Group highlights its role as a leading mechanical and electrical contractor, especially in data centers.
At Morgan Stanley's 14th Annual Laguna Conference, EMCOR Group's CEO Anthony Guzzi explained that the company specializes in installing, repairing, and maintaining mechanical and electrical systems across various sectors including healthcare, commerc...

Boomers held Bitcoin ETFs through 54% crash but missed 16% S&P 500 rally
Baby Boomers showed discipline by holding Bitcoin ETFs despite a 54% price crash over the past year. However, while they stayed loyal to Bitcoin ETFs, the S&P 500 ETF rose 15.5%, meaning they missed out on the best broad-market gains in a decade. The...

Solar stocks rebound sharply with Sunrun and First Solar up 6% amid sector-wide buying, no new news.
Solar stocks surged Thursday with Sunrun and First Solar leading gains at 6%, followed by SolarEdge rising 4%. This rally occurred without any new earnings, analyst upgrades, or policy changes, indicating a sector-wide rebound rather than company-spe...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.